Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

MicroStrategy’s Bitcoin Bet Faces Market Skepticism

Dieter Jaworski by Dieter Jaworski
November 11, 2025
in Analysis, Bitcoin, Crypto Stocks, Trading & Momentum
0
Strategy Stock
0
SHARES
136
VIEWS
Share on FacebookShare on Twitter

The prominent corporate Bitcoin accumulator is facing significant headwinds. MicroStrategy shareholders have endured a turbulent descent in recent weeks, despite the company’s unwavering commitment to expanding its cryptocurrency reserves. In a surprising twist, a notable short seller has now thrown in the towel, leaving market participants to wonder whether this signals a potential reversal or merely a temporary pause before further declines.

Unwavering Accumulation Amid Market Pressure

Even as its stock price faltered, MicroStrategy maintained its aggressive Bitcoin acquisition strategy. Between November 3rd and November 9th, the company purchased an additional 487 Bitcoin for approximately $49.9 million. This latest acquisition brings their colossal holdings to 641,692 BTC.

The company has employed multiple financing methods to sustain its buying spree:
* At-the-market offerings involving various classes of preferred shares
* High-yield preferred stock issuances
* Aggressive capital market initiatives that have raised concerns about shareholder dilution

Notable Short Seller Exits Position

A significant development emerged when prominent investor Jim Chanos closed his short position against MicroStrategy after maintaining it for eleven months. Chanos, renowned for his successful bets against overvalued companies, chose to exit precisely as the stock experienced substantial depreciation.

Should investors sell immediately? Or is it worth buying Strategy?

The metrics reveal a compelling narrative: When Chanos initially established his short position, the market value to Bitcoin holdings ratio (mNAV) stood at 2.50. This premium has since contracted dramatically to 1.23. The short seller’s capitulation may serve as a technical buying indicator, particularly for traders with shorter time horizons.

Decoupling from Bitcoin and Technical Concerns

Market sentiment has turned punishing for MicroStrategy shares, which recently touched a new 52-week low and trade significantly below their annual peaks. A troubling pattern has emerged as the stock demonstrates increasing divergence from Bitcoin’s performance. While the cryptocurrency itself has maintained relative stability, selling pressure on MicroStrategy shares has intensified.

Market technicians are closely monitoring a critical support level. A sustained breach below this threshold could potentially trigger additional selling waves. With annualized volatility approaching 58 percent, the security has become predominantly attractive to speculative traders.

Analyst Sentiment Shifts

Investment firm Monness Crespi Hardt recently downgraded MicroStrategy to a “Neutral” rating, citing the diminished premium relative to the company’s Bitcoin reserves. Although numerous analysts maintain “Buy” recommendations, caution appears to be growing across the research community. The fundamental question remains whether MicroStrategy can continue leveraging its Bitcoin narrative effectively or if the company’s financing approach will ultimately constrain its progress.

Ad

Strategy Stock: Buy or Sell?! New Strategy Analysis from February 7 delivers the answer:

The latest Strategy figures speak for themselves: Urgent action needed for Strategy investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Strategy: Buy or sell? Read more here...

Tags: Strategy
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Avanos Medical Stock
Analysis

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

February 7, 2026
Guaranty Bancshares Stock
Analysis

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

February 7, 2026
Yirendai Stock
AI & Quantum Computing

Yirendai Charts a New Course with Tech-Driven Strategy

February 7, 2026
Next Post
LVMH Stock

LVMH Shares Find Momentum as Chinese Demand Rebounds

NASDAQ 100 Stock

Tech Stocks Surge as US Government Shutdown Fears Ease

IonQ Stock

Quantum Computing's Financial Paradox: IonQ's High-Stakes Balancing Act

Recommended

C3.ai Stock

Is C3.ai Stock Poised for a Rebound?

2 months ago
MMM stock news

Clarification on Hyperlink and Promotional Fees

2 years ago

XOMA Corporation Expands Portfolio with Acquisition of DSUVIA

2 years ago
Microsoft Stock

A Bold Bet: Peter Thiel’s Hedge Fund Doubles Down on Microsoft

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

ServiceNow Shares Face Market Skepticism Despite Record Performance

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

A New Chapter for First Busey as CrossFirst Merger Finalizes

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Trending

Avanos Medical Stock
Analysis

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

by SiterGedge
February 7, 2026
0

Avanos Medical is navigating a critical strategic transformation. The medical device firm is streamlining its operations to...

Guaranty Bancshares Stock

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

February 7, 2026
Yirendai Stock

Yirendai Charts a New Course with Tech-Driven Strategy

February 7, 2026
ServiceNow Stock

ServiceNow Shares Face Market Skepticism Despite Record Performance

February 7, 2026
Orthofix Medical Stock

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth
  • Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion
  • Yirendai Charts a New Course with Tech-Driven Strategy

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com